Journal
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Volume 36, Issue 3, Pages 412-415Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2710.2011.01267.x
Keywords
adrenoleukodystrophy; d-ROM; edaravone; free-radical scavenger; nitrite; nitrate; short latency somatosensory evoked potential
Categories
Ask authors/readers for more resources
P>What is known and Objective: Adrenoleukodystrophy (ALD) is an X-linked disorder and characterized by the accumulation of saturated very long-chain fatty acids. Treatment is still unsatisfactory. Our objective is to report on the effect of the free-radical scavenger, edaravone, in a patient with ALD. Case summary: The patient was given edaravone intravenously twice. D-ROM in cerebral spinal fluid decreased dramatically, and a shortening of neuronal transmission time as estimated on somatosensory evoked potential was observed. After terminating the treatment, his symptoms progressively reappeared. What is new and Conclusion: This is the first report of the use of edaravone in ALD. The drug is apparently effective in improving symptoms of ALD and should be evaluated more formally.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available